These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28068907)

  • 1. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
    Bieh KL; Weigel R; Smith H
    BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
    McNally TW; de Wildt G; Meza G; Wiskin CMD
    BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
    Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
    PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring health care providers' engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study.
    Lajore BA; Aweke YH; Ayanto SY; Ayele M
    BMC Health Serv Res; 2024 Apr; 24(1):542. PubMed ID: 38678263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.
    Horter S; Stringer B; Reynolds L; Shoaib M; Kasozi S; Casas EC; Verputten M; du Cros P
    BMC Health Serv Res; 2014 Feb; 14():81. PubMed ID: 24559177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
    Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
    BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
    Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K
    Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes.
    Oga-Omenka C; Bada F; Agbaje A; Dakum P; Menzies D; Zarowsky C
    Int J Equity Health; 2020 Dec; 19(1):221. PubMed ID: 33302956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
    Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
    BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective.
    Morris MD; Quezada L; Bhat P; Moser K; Smith J; Perez H; Laniado-Laborin R; Estrada-Guzman J; Rodwell TC
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):954-60. PubMed ID: 23743315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    Bada FO; Blok N; Okpokoro E; Dutt S; Akolo C; Dakum P; Abimiku A
    PLoS One; 2020; 15(12):e0241065. PubMed ID: 33259492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients' perspectives from a focus group discussion.
    Mpagama SG; Ezekiel MJ; Mbelele PM; Chongolo AM; Kibiki GS; de Guex KP; Heysell SK
    BMC Public Health; 2020 Nov; 20(1):1667. PubMed ID: 33160327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Horter S; Stringer B; Gray N; Parpieva N; Safaev K; Tigay Z; Singh J; Achar J
    BMC Infect Dis; 2020 Sep; 20(1):675. PubMed ID: 32938422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
    Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
    PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Support and unmet needs of patients undergoing multidrug-resistant tuberculosis (MDR-TB) treatment in southern Nigeria.
    Oshi D; Chukwu J; Nwafor C; Chukwu NE; Meka AO; Anyim M; Ukwaja KN; Alobu I; Ekeke N; Oshi SN
    Int J Health Plann Manage; 2020 Jul; 35(4):832-842. PubMed ID: 31849112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
    Khanal S; Elsey H; King R; Baral SC; Bhatta BR; Newell JN
    PLoS One; 2017; 12(1):e0167559. PubMed ID: 28099475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaboration for implementation of decentralisation policy of multi drug-resistant tuberculosis services in Zambia.
    Chavula MP; Matenga TFL; Maritim P; Munakampe MN; Habib B; Liusha N; Banda J; Sinyangwe NN; Halwiindi H; Mweemba C; Mubanga A; Kaonga P; Chewe M; Phiri H; Zulu JM
    Health Res Policy Syst; 2024 Aug; 22(1):112. PubMed ID: 39160603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Horter S; Achar J; Gray N; Parpieva N; Tigay Z; Singh J; Stringer B
    PLoS One; 2020; 15(11):e0242359. PubMed ID: 33237960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
    Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.